Sun L, He Y, Xu L, Zhao F, et al. Higher Risk of Dyslipidemia With Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide than Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate Among Antiretroviral-Naive People Living With HIV in China. J Acquir Immune Defic Syndr 2022;91.
PMID: 36094509